Drugs / MSC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06805448 | Jan → Dec 2025 overdue | Sjogren syndrome | Rigshospitalet, Denmark | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MSC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06805448 ↗ |
| Modality | Cell therapy | “mesenchymal stem cells” NCT06805448 ↗ |
| Route | Other | “injecting either stem cells or a placebo into the two saliva glands near the jaw” NCT06805448 ↗ |